Clinical Research Proposals support research institutions studying sleep-disordered breathing and respiratory disorders, funding clinical research that can inform diagnosis, treatment, and patient care.
Funder: ResMed Foundation
Due Dates (Anticipated): December 2026 | March 2027 | June 2027 | September 2027
Funding Amounts: Up to $1,350,000 in total foundation grants annually; multi-year studies considered
Summary: Supports clinical research on sleep-disordered breathing and other respiratory disorders with findings that can inform clinical practice.
Key Information: Applicants must be qualified tax-exempt organizations or hold an equivalent designation outside the United States.
The ResMed Foundation supports novel clinical research on sleep-disordered breathing and other respiratory disorders, with a primary focus on positive airway pressure and ventilation-based treatments. Proposals may address evaluation, diagnosis, treatment, or management. The foundation emphasizes outcomes that can be translated into clinical practice and encourages publication in peer-reviewed scientific and medical journals.
Research interests include links between sleep-disordered breathing and cardiovascular disease, metabolic syndrome, insulin sensitivity, and obesity, as well as insomnia, occupational health and safety, asthma, and chronic obstructive pulmonary disease. Current priorities include better monitoring of disease severity, novel uses of positive airway pressure, advanced analytics and data science, health economics and outcomes research, pragmatic trials, remote chronic disease management, and the future of sleep labs.